Cardiovascular diseases constitute a major group of chronic non-communicable diseases (NCDs) of greatest relevance to public health in xx. Systemic Arterial Hypertension (SAH) is an NCD recognized as one of the leading independent and reversible risk factors for cardiovascular disease. In xx, primary care—owing to its comprehensive, patient-centered, and community-based model—ensures greater accessibility and reach for the prevention and early detection of conditions such as SAH.To characterize the profile of individuals diagnosed with systemic arterial hypertension who were registered with and monitored by a Family Health Strategy (FHS) team in a Primary Health Care Unit in the municipality of xxThis was a retrospective, cross-sectional epidemiological study with a quantitative approach, based on secondary data extracted from the Integrated Health Management and Services System (SIGSS) of xx. Electronic medical records of 292 individuals with SAH, followed between January 2022 and December 2024, were evaluated regarding sociodemographic variables, clinical characteristics, risk factors, target-organ damage, pharmacotherapy, and cardiovascular risk stratification.There was a predominance of female participants (64.4%) and of individuals aged 60–69 years, highlighting the association between SAH and aging. Most patients were classified as White (85.3%). Excess body weight was highly prevalent, with 35.3% presenting overweight and 24% class I obesity. Modifiable factors such as smoking, alcohol consumption, and physical inactivity showed a high proportion of missing data. Diabetes mellitus was identified in 28.1% of the sample.Regarding target-organ damage, 29.1% had a history of cardiovascular disease, notably stroke, myocardial infarction, and chronic kidney disease. Antihypertensive therapy was used by 96.7% of participants, with frequent combination regimens involving ARBs/ACE inhibitors, thiazide diuretics, and beta-blockers. However, formal cardiovascular risk stratification was absent in 79.8% of the records. Among those with documented risk classification, most were categorized as high risk, although a portion were not receiving high-intensity statins as currently recommended.Although clinical follow-up is provided, significant gaps persist in risk stratification and in the recording of essential information, directly affecting primary care’s capacity to plan and guide interventions. The findings underscore the need for improved documentation practices, continuous professional development, and the adoption of standardized protocols.